# Contributions of Sleep and Pain to Alzheimer's Disease Related Biomarkers: Identifying Modifiable  Risk Factors in Women with Normal to Mildly Impaired Cognitive Function

> **NIH NIH R01** · UNIVERSITY OF MISSOURI-COLUMBIA · 2021 · $380,081

## Abstract

PROJECT SUMMARY
This supplement will increase understanding of modifiable Alzheimer’s disease related risk factors (sleep, pain, arousal),
and their associations and interactions with Alzheimer’s disease related biomarkers, cognition, and daytime functioning in
three groups of middle-to-older aged women characterized by: fibromyalgia and insomnia (FMI), subclinical sleep and pain
complaints (SPC), or mild cognitive impairment (MCI). Women are at greater risk (2x) of Alzheimer’s disease, and the vast
majority (2/3rds) of Americans with Alzheimer’s disease are women. Chronic pain, poor sleep, and MCI are independently
associated with greater risk of neurodegenerative disorders, and increased levels of biomarkers associated with Alzheimer’s
disease (amyloid beta-Aβ, tau) and inflammation (C-reactive Protein-CRP, IL-6). Thus, these groups are ideal for studying
these factors and addressing the lack of understanding of the mechanisms underlying their association and the degree to
which modifiable factors (sleep, pain, arousal) may interact to mitigate Alzheimer’s disease risk, onset or progression.
 The parent study, a NIH/NINR funded randomized clinical trial (RCT), focuses on the mechanistic roles of sleep and
arousal in chronic pain and pain-related neural plasticity. Our team does not currently conduct Alzheimer’s disease focused
research, and the parent trial does not have an Alzheimer’s disease focus. Nonetheless, it offers a unique opportunity to
examine the associations and interactions amongst the modifiable Alzheimer’s disease related factors measured in the parent
trial (sleep, pain, arousal) and the Alzheimer’s disease related biomarkers, cognition, and daytime functioning measures
proposed in this supplement. This supplement is an important first step for our team to develop an Alzheimer’s disease
research focus based on a biopsychosocial model in which the associations of sleep, pain, and arousal with Alzheimer’s
disease related biomarkers, cognition, and daytime functioning are moderated by sex hormones, APOE genotype, age, and
education. This supplement takes advantage of the parent trial’s infrastructure, data, and well-characterized samples of FMI
and SCP. 30 women with FMI and 60 with SCP will be recruited for the supplement from the parent trial’s baseline screening
phase. Additionally, a new sample of 30 women with MCI will be recruited.
 This supplement tests two specific aims: Aims 1 and 2 examine the associations and interactions amongst sleep, pain,
arousal, and Alzheimer’s related biomarkers, cognition, and daytime functioning, and their moderation by sex hormones,
APOE genotype, age, and education in women with FMI, SPC, or MCI. While these aims involve data collected during the
screening phase of the parent trial, the parent trial also examines the impact of cognitive behavioral treatment for insomnia
(CBT-I) on sleep, pain, arousal, central sensitization, and neural plasticity in women with FMI. Thus, an Exploratory Aim
in...

## Key facts

- **NIH application ID:** 10289504
- **Project number:** 3R01NR017168-03S1
- **Recipient organization:** UNIVERSITY OF MISSOURI-COLUMBIA
- **Principal Investigator:** Christina S McCrae
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $380,081
- **Award type:** 3
- **Project period:** 2021-05-01 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10289504

## Citation

> US National Institutes of Health, RePORTER application 10289504, Contributions of Sleep and Pain to Alzheimer's Disease Related Biomarkers: Identifying Modifiable  Risk Factors in Women with Normal to Mildly Impaired Cognitive Function (3R01NR017168-03S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10289504. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*